Industries > Pharma > Pharma Wholesale and Distribution Market: World Outlook 2013-2023

Pharma Wholesale and Distribution Market: World Outlook 2013-2023

PUBLISHED: 03 June 2013
PAGES: 203
SUBMARKET: Contract Services

WOOCS 2.2.1
SKU: N/A Categories: ,

Discover trends and revenue potential in distributing and wholesaling of medicines

Where's the drug wholesaling and distribution market heading? Visiongain's updated report predicts revenues there from 2013 to 2023. It also explains trends in business and technology, prospects, and opportunities to help your work.

In that study you gain sales forecasts at overall world market, submarket, company, and national level. Find what's happening. Also discover what has most growth potential.

Read on to explore the drug distribution industry and see what its future market could be worth.

Forecasts and other information to benefit your knowledge

Is finding data a challenge? Avoid falling behind for supply of medicines. You can now stay ahead in information, benefiting your research, analyses, and decisions. Also save time.

Besides revenue forecasting, our new work shows historical data, growth rates, and market shares. You discover original quantitative and qualitative analysis, seeing business outlooks and developments. You also gain 68 tables, 95 charts, and three research interviews.

There you investigate the future of the supply chain for human medicines. You find what's happening and see where the money lies. Finding data you need has just got easier.

Anyhow, the following sections show what you get in our investigation and analysis.

See prospects for the world market and submarkets

Our new report shows revenue to 2023 for the overall world market. It also shows you individual forecasts for three submarkets:
• Original branded drugs
• Generic drugs
• Other products.

How will the pharmaceutical wholesale and distribution (W&D) market grow? Which parts will most prosper? There you assess potential for sales and revenue growth.

Also our study discusses what stimulates and restrains business for distributing drugs. That analysis helps you identify potential and find ways for your business to grow.

You also see geographical revenue predictions.

What sales potential for leading countries?

Developments worldwide expand the pharma W&D market, especially rising demand for medicines in emerging countries. China, India, Russia, and Brazil underpin revenue growth.

In developed and developing countries, opportunities for drug wholesalers and other medical suppliers will occur from 2013. Pharmacies also stand to benefit. See how.

Our report shows you individual revenue forecasts to 2023 for 11 national markets:
• US
• Japan
• Germany, France, UK, Italy, and Spain (EU5)
• Brazil, Russia, India, and China (BRIC).

There you discover progress and outlooks. You assess the W&D industry's future – hear about developments and find their significance. Our work explains.

That analysis shows highest revenue growth to 2023 will occur in developing countries. Developed markets will expand too. You investigate, also finding the potential of companies.

Find revenue forecasts and other information for leading firms

How will leading companies perform to 2023 at world level? Our work shows you individual revenue forecasts for 11 top wholesalers and distributors, including these:
• McKesson
• Cardinal Health
• AmerisourceBergen
• Alliance Boots
• Medipal
• Sinopharm
• Suzuken.

There you assess those organisations, seeing activities, results, and outlooks. You discover what's happening, understanding trends, competition, challenges, and opportunities.

That way you assess the future, hearing about progress and finding its significance. Our study explains, exploring many issues.

What affects the supply of pharmaceuticals through distribution networks?

Our report discusses issues and events affecting that industry and market from 2013, including these:
• Roles of pharmaceutical wholesalers
• Revenues, costs, and profits
• Use of new technologies
• Direct-to-pharmacy (DTP) activities
• Pharmacy benefit managers
• Forward buying and fee-for-service
• Discounts, clawbacks, and parallel trade.

The work also discusses other aspects of the industry, including these:
• Chain pharmacies and vertical integration
• State-funded healthcare and reimbursement
• Pre-wholesaling and pre-financing
• Rise of specialty medicines, including biologics, and generic drugs (generics)
• Actions against pharmaceutical counterfeiting
• Budget cuts in healthcare
• Changes to regulations
• Globalisation and consolidation of the industry.

That way, you explore technological, economic, social, and political (STEP) questions, assessing outlooks for the business. You also analyse that industry's strengths, weaknesses, opportunities, and threats (SWOT).

See, then, what the future holds.

What's the 2017 market value?

Our study predicts the world market for drug wholesaling and distribution will reach $966bn in 2017, and expand further to 2023. See how high turnover can go, and find what influences revenues and profits.

Also, some medical wholesalers and distributers are expanding into retail pharmacy, and even into drug production. W&D evolves – you see how and assess its future.

Discover now revenues and opportunities for the W&D industry – established and rising companies. That market holds potential from 2013 for investment, development, and sales growth. Our new report shows you the possibilities.

Nine ways Pharma Wholesale and Distribution Market: World Outlook 2013-2023 helps

To sum up, our analysis gives you the following knowledge:
• Revenue to 2023 for the world pharma W&D market – discover that industry's sales potential
• Revenues to 2023 for 3 world-level submarkets – investigate the potential of its components, finding the most promising places for investments and revenues
• Revenues to 2023 for 11 leading companies – find sales forecasts for top players, seeing how those participants can compete and succeed
• Forecasts to 2023 for 11 leading national markets in the Americas, Europe, and Asia – discover the best countries for revenues and potential growth
• Activities of leading companies – analyse participants' results, actions, capabilities, and outlooks
• Discussions of progress and market expansion – investigate developments, exploring possibilities for technological and commercial advances
• Interviews with authorities – discover debates and opinions to help you stay ahead
• Competition and opportunities – see what affects the W&D industry, learning what shapes its future, esp. prospects for sustaining and developing business
• Analysis of what stimulates and restrains that industry and market – assess challenges and strengths, helping you compete and get advantages.

You gain information found nowhere else

That work gives independent analysis. You receive business intelligence found only in our report, seeing where prospects are most rewarding.

With our study you are less likely to fall behind in knowledge or miss opportunity. See how you could benefit your research, analyses, and decisions, also saving time and getting you recognition for insight.

Our analysis costs only a tiny fraction of potential profits from your understanding and harnessing the pharma W&D market. See its growth potential and find what you can gain.

Ordering now lets you discover predictions and opportunities for drug supply

Our new study is for everyone analysing the industry and market for supplying medicines. There you find data, trends, opportunities, and growth predictions. Avoid missing out – please order our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

To view free sample pages of this report please click here

Download sample pages

Complete the form below to download your free sample pages for Pharma Wholesale and Distribution Market: World Outlook 2013-2023

Download sample pages

Complete the form below to download your free sample pages for Pharma Wholesale and Distribution Market: World Outlook 2013-2023

Latest Pharma news

Visiongain Publishes Single-Cell Analysis Market Report 2022-2032

The global single cell analysis market was valued at US$3,255.0 million in 2022 and is projected to grow at a CAGR of 15.1% during the forecast period 2022-2032.

26 May 2022


Visiongain Publishes Ophthalmic Devices Market Report 2022-2032

The number of people who are blind or have poor vision is expected to rise considerably in the coming years. The growing elderly population is one of the key drivers of the Ophthalmic Devices Market’s upward trend.

19 April 2022


Visiongain Publishes Vaccine Contract Manufacturing Market Report 2022-2032

The growing global health system has made significant contributions to protecting and promoting human health. However, long-standing, developing, and reemerging infectious disease risks continue to plague the planet

13 April 2022


Visiongain Publishes Pharmaceutical Contract Manufacturing Market Report 2022-2032

The major driving factor contributing towards the growth of pharmaceutical contract manufacturing market are increase in investments in pharmaceutical R&D, rise in number of patent expiry, rising demand of generic drugs, and investment in advanced manufacturing technologies. However, use of serialization can thwart the market growth.

13 April 2022